Gillespie; Roger John

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gillespie; Roger John.The latest application filed is for "triazolo[4,5-d] pyramidine derivatives and their use as purine receptor antagonists".

Company Profile

5.29.28

Gillespie; Roger John - Winnersh GB
Gillespie; Roger John - Nr. Malmesbury GB
Gillespie; Roger John - Wokingham GB
Gillespie; Roger John - Berkshire GB
Gillespie; Roger John - Oaksey GB
Gillespie, Roger John - Winnersh Wokingham GB
Gillespie, Roger John - Wilts GB
Gillespie; Roger John - Malmesbury GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Triazolo[4,5-d] Pyramidine Derivatives And Their Use As Purine Receptor Antagonists App 20210115054 - Bamford; Samantha Jane ; et al.	2021-04-22
Triazolo[4,5-d] pyramidine derivatives and their use as purine receptor antagonists Grant 10,875,868 - Bamford , et al. December 29, 2	2020-12-29
Triazolo[4,5-d] Pyramidine Derivatives And Their Use As Purine Receptor Antagonists App 20200172547 - Bamford; Samantha Jane ; et al.	2020-06-04
Triazolo[4,5-D] pyramidine derivatives and their use as purine receptor antagonists Grant 10,538,526 - Bamford , et al. Ja	2020-01-21
Triazolo[4,5-d] Pyramidine Derivatives And Their Use As Purine Receptor Antagonists App 20190031668 - Bamford; Samantha Jane ; et al.	2019-01-31
Triazolo[4,5-D] pyramidine derivatives and their use as purine receptor antagonists Grant 10,106,547 - Bamford , et al. October 23, 2	2018-10-23
Triazolo[4,5-d] Pyramidine Derivatives And Their Use As Purine Receptor Antagonists App 20170342081 - Bamford; Samantha Jane ; et al.	2017-11-30
Triazolo[4,5-D] pyramidine derivatives and their use as purine receptor antagonists Grant 9,765,080 - Bamford , et al. September 19, 2	2017-09-19
Triazolo[4,5-d] Pyramidine Derivatives And Their Use As Purine Receptor Antagonists App 20170088552 - Bamford; Samantha Jane ; et al.	2017-03-30
Triazolo[4,5-D] pyramidine derivatives and their use as purine receptor antagonists Grant 9,376,443 - Bamford , et al. June 28, 2	2016-06-28
Triazolo[4,5-d] Pyramidine Derivatives And Their Use As Purine Receptor Antagonists App 20150291602 - Bamford; Samantha Jane ; et al.	2015-10-15
Triazolo [4, 5-D] pyramidine derivatives and their use as purine receptor antagonists Grant 8,987,279 - Bamford , et al. March 24, 2	2015-03-24
Triazolo[4, 5-d] Pyramidine Derivatives And Their Use As Purine Receptor Antagonists App 20130245044 - Bamford; Samantha Jane ; et al.	2013-09-19
Triazolo[4,5-D]pyramidine derivatives and their use as purine receptor antagonists Grant 8,450,328 - Bamford , et al. May 28, 2	2013-05-28
Inhibitors Of Interleukin-1 Beta Converting Enzyme App 20120165319 - Batchelor; Mark James ; et al.	2012-06-28
Inhibitors of interleukin-1.beta. converting enzyme Grant 8,119,631 - Batchelor , et al. February 21, 2	2012-02-21
Inhibitors Of Interleukin-1 Beta Converting Enzyme App 20110178069 - Batchelor; Mark James ; et al.	2011-07-21
Triazolo[4,5-d]pyramidine Derivatives And Their Use As Purine Receptor Antagonists App 20110172252 - Bamford; Samantha Jane ; et al.	2011-07-14
Pyrimidine compounds as purine receptor antagonist Grant 7,875,600 - Gillespie , et al. January 25, 2	2011-01-25
Inhibitors of interleukin-1.beta. converting enzyme Grant 7,790,713 - Batchelor , et al. September 7, 2	2010-09-07
Pyrazolo [3,4-d] pyrimidine derivatives and their use as purinergic receptor antagonists Grant 7,629,349 - Gillespie , et al. December 8, 2	2009-12-08
Pyrrolo [2,3-d] pyrimidine and their use as purinergic receptor antagonists Grant 7,598,256 - Gillespie , et al. October 6, 2	2009-10-06
Triazol[4,5-d] pyramidine derivatives and their use as purinergic receptor antagonists Grant 7,589,097 - Gillespie , et al. September 15, 2	2009-09-15
Purine derivatives as purinergic receptor antagonists Grant 7,452,894 - Gillespie , et al. November 18, 2	2008-11-18
Triazolo[4,5-d] pyramidine derivatives and their use as purinergic receptor antagonists App 20080234296 - Gillespie; Roger John ; et al.	2008-09-25
Pyrimidine Compounds as Purine Receptor Antagonist App 20080182860 - Gillespie; Roger John ; et al.	2008-07-31
Triazolo [4,5-d] pyrimidine derivatives and their use as purinergic receptor antagonists Grant 7,405,219 - Gillespie , et al. July 29, 2	2008-07-29
Thieno(3,2-d)pyrimidines and furano(3,2-d)pyramidines and their use as purinergic receptor antagonists App 20080153820 - Gillespie; Roger John ; et al.	2008-06-26
Thieno(3,2-d)pyrimidines and furano(3,2-d)pyrimidines and their use as purinergic receptor antagonists Grant 7,384,949 - Gillespie , et al. June 10, 2	2008-06-10
Inhibitors of interleukin-1beta converting enzyme App 20080039449 - Batchelor; Mark James ; et al.	2008-02-14
Pyrimidine Compounds as Purine Receptor Antagonist App 20070281936 - Gillespie; Roger John ; et al.	2007-12-06
Triazolo [4,5-d] pyrimidine derivatives and their use as purinergic receptor antagonists App 20070049607 - Gillespie; Roger John ; et al.	2007-03-01
Purine derivatives as purinergic receptor antagonists App 20060270691 - Gillespie; Roger John ; et al.	2006-11-30
Triazolo[4,5-d]pyrimidine derivatives and their use as purinergic receptor antagonists Grant 7,141,575 - Gillespie , et al. November 28, 2	2006-11-28
Pyrrolo[2,3-d]pyrimidine and their use as purinergic receptor antagonists Grant 7,098,333 - Gillespie , et al. August 29, 2	2006-08-29
Pyrazolo[3,4-d]pyrimidine derivatives and their use as purinergic receptor antagonists Grant 7,087,754 - Gillespie , et al. August 8, 2	2006-08-08
Pyrrolo [2,3-d] pyrimidine and their use as purinergic receptor antagonists App 20060128731 - Gillespie; Roger John ; et al.	2006-06-15
Pyrazolo [3,4-d] Pyrimidine Derivatives And Their Use As Purinergic Receptor Antagonists App 20060111373 - Gillespie; Roger John ; et al.	2006-05-25
Inhibitors of interleukin-1beta converting enzyme App 20050143436 - Batchelor, Mark James ; et al.	2005-06-30
2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission Grant 6,828,318 - Snape , et al. December 7, 2	2004-12-07
Thieno-and furopyrimidine derivatives as A2A-receptor antagonists Grant 6,787,541 - Gillespie , et al. September 7, 2	2004-09-07
Pyrazolo[3,4-d]pyrimidine derivatives and their use as purinergic receptor antagonists App 20040116447 - Gillespie, Roger John ; et al.	2004-06-17
Purine derivatives as purinergic receptor antagonists App 20040102459 - Gillespie, Roger John ; et al.	2004-05-27
Thieno(3,2-d)pyrimidines and furano(3,2-d)pyimidines and their use as purinergic receptor antagonists App 20040097524 - Gillespie, Roger John ; et al.	2004-05-20
Triazolo[4,5-d]pyrimidine derivatives and their use as purinergic receptor antagonists App 20040097526 - Gillespie, Roger John ; et al.	2004-05-20
Pyrrolo[2,3-d]pyrimidine and their use as purinergic receptor antagonists App 20040092537 - Gillespie, Roger John ; et al.	2004-05-13
Inhibitors of interleukin-1beta converting enzyme App 20030225269 - Batchelor, Mark James ; et al.	2003-12-04
2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission App 20030207881 - Snape, Michael Frederick ; et al.	2003-11-06
4-quinolinemethanol derivatives as purine receptor antagonists (II) Grant 6,608,085 - Gillespie , et al. August 19, 2	2003-08-19
1-(Adamantyl) amidines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission App 20030130354 - Gillespie, Roger John ; et al.	2003-07-10
4-Quinolinemethanol derivatives as purine receptor antagonists (1) Grant 6,583,156 - Gillespie , et al. June 24, 2	2003-06-24
Inhibitors of interleukin-1.beta. converting enzyme Grant 6,423,840 - Batchelor , et al. July 23, 2	2002-07-23
Inhibitors of Interleukin-1.beta. converting enzyme Grant 6,258,948 - Batchelor , et al. July 10, 2	2001-07-10
Inhibitors of interleukin-1.beta. Converting enzyme inhibitors Grant 6,204,261 - Batchelor , et al. March 20, 2	2001-03-20
Inhibitors of interleukin-1.beta. converting enzyme Grant 6,008,217 - Batchelor , et al. December 28, 1	1999-12-28
Inhibitors of interleukin-1.beta. converting enzyme Grant 5,874,424 - Batchelor , et al. February 23, 1	1999-02-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.